MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013
Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation? Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Investigation of angiogenetic markers (ENA-78 and GRO-α) in patients with pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005
Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
Influence of leucocytes on Interleukin-8 (IL-8) in sputum and whole blood in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018
Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021
PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021
Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage Source: International Congress 2016 – Orphan diseases I Year: 2016
Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011
Osteopontin and interleukin-6 as biomarkers of interstitial lung disease Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018
TNF-α, IL-6, IL-10 serum activity in patients with obesity-associated arterial hypertension depend on bronchial obstruction presence Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005